Biblio
Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC. Front Immunol. 2024;15:1376045.
. Game-changing insights on vertebral skeletal stem cells in bone metastasis and therapeutic horizons. Oncol Res. 2023;32(1):95-98.
. Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy. Oncol Res. 2023;32(1):49-60.
. Targeting HER3 to overcome EGFR TKI resistance in NSCLC. Front Immunol. 2023;14:1332057.
.